Special coverage: 11th retroviruses conference. Novel approaches to HIV vaccine are being studied. One possibility is vaccine that slows disease.
Dozens of potential HIV vaccine candidates have been studied, and many of the latest additions include novel strategies to elicit HIV antibodies and cytotoxic T-cells, as well as some that may help slow disease progression. Here's a look at some of the talk at the 11th Conference on Retroviruses and Opportunistic Infections.
D016915:AIDS Vaccines / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology; D018450:Disease Progression; D005822:Genetic Vectors; D015658:HIV Infections / Q000503:physiopathology*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D009500:Neutralization Tests; D016092:Spumavirus / Q000235:genetics
D016915:AIDS Vaccines